Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Aeon Biopharma | AEON | Nov 21, 2024 | 0.56 | -0.82 |
AerCap Holdings | AER | Nov 21, 2024 | 97.72 | +2.59 |
Aeries Technology | AERT | Nov 21, 2024 | 1.15 | -7.26 |
Aerospace & Defense Powershares | PPA | Nov 21, 2024 | 119.55 | +0.89 |
Aerovate Therapeutics | AVTE | Nov 21, 2024 | 2.61 | -1.88 |
AeroVironment | AVAV | Nov 21, 2024 | 194.26 | -2.06 |
AerSale | ASLE | Nov 21, 2024 | 6.40 | +3.39 |
AES | AES | Nov 21, 2024 | 13.25 | -0.23 |
Aetherium Acquisition A | GMFI | Nov 21, 2024 | 11.04 | 0.00 |
Aetherium Acquisition Unit | GMFIU | Nov 21, 2024 | 11.10 | 0.00 |
Aethlon Medical | AEMD | Nov 21, 2024 | 0.39 | -1.15 |
Aeva Technologies | AEVA | Nov 21, 2024 | 3.77 | +9.28 |
AEye A | LIDR | Nov 21, 2024 | 0.92 | +0.02 |
Affiliated Managers Group | AMG | Nov 21, 2024 | 186.59 | +0.66 |
Affimed N.V. | AFMD | Nov 21, 2024 | 2.64 | -2.94 |
Affinity Bancshares | AFBI | Nov 21, 2024 | 21.46 | -0.19 |
Affirm A | AFRM | Nov 21, 2024 | 65.74 | +4.04 |
Aflac | AFL | Nov 21, 2024 | 111.73 | +1.35 |
Africa Index ETF Market Vectors | AFK | Nov 21, 2024 | 16.07 | +1.71 |
Afya A | AFYA | Nov 21, 2024 | 16.26 | -0.61 |
Ag Mortgage Investment Trust | MITT | Nov 21, 2024 | 6.66 | +0.15 |
AG Mortgage Investment Trust A Pref | MITT-A | Nov 21, 2024 | 22.34 | 0.00 |
AG Mortgage Investment Trust B Pref | MITT-B | Nov 21, 2024 | 22.38 | +0.27 |
AG Mortgage Investment Trust C Pref | MITT-C | Nov 21, 2024 | 25.30 | 0.00 |
Agape ATP | ATPC | Nov 21, 2024 | 1.52 | +5.56 |
AGBA Group | AGBA | Nov 21, 2024 | 1.40 | 0.00 |
AGCO | AGCO | Nov 21, 2024 | 97.45 | +5.95 |
AgEagle Aerial Systems | UAVS | Nov 21, 2024 | 3.20 | -12.09 |
Agency Bond Ishares | AGZ | Nov 21, 2024 | 108.28 | -0.11 |
Agenus | AGEN | Nov 21, 2024 | 2.86 | +7.12 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.